Centering the patient in decisions about opioid tapering

References

• Keefe PR The Family That Built an Empire of Pain. The New Yorker [Internet]. 2017 Oct 23 [cited 2024 Jan 24]. Available from: https://www.newyorker.com/magazine/2017/10/30/the-family-that-built-an-empire-of-pain
   Google Scholar
• Spencer MR, Minino AM, Warner M Drug overdose deaths in the United States, 2001–2021 [Internet]. National Center for Health Statistics; 2022. Report No.: 457. Available from: https://www.cdc.gov/nchs/products/index.htm
   Google Scholar
• Schieber LZ, GP G Jr, Seth P, et al. Trends and patterns of geographic variation in opioid prescribing practices by State, United States, 2006-2017. JAMA Netw Open. 2019;2(3):e190665. doi: 10.1001/jamanetworkopen.2019.0665
   PubMed Web of Science ®Google Scholar
• Chou R, Hartung D, Turner J, et al. Opioid treatments for chronic pain [internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 [cited 2024 Jan 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK556253/
   Google Scholar
• Dowell D, Ragan KR, Jones CM, et al. CDC clinical practice guideline for prescribing opioids for pain — United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95. doi: 10.15585/mmwr.rr7103a1
   PubMed Web of Science ®Google Scholar
• Agnoli A, Xing G, Tancredi DJ, et al. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326(5):411–419. doi: 10.1001/jama.2021.11013
   PubMed Web of Science ®Google Scholar
• Hallvik SE, El Ibrahimi S, Johnston K, et al. Patient outcomes following opioid dose reduction among patients with chronic opioid therapy. Pain. 2021;163(1):83–90. doi: 10.1097/j.pain.0000000000002298
   Web of Science ®Google Scholar
• Mark TL, Parish W. Opioid medication discontinuation and risk of adverse opioid-related health care events. J Subst Abuse Treat. 2019 May 14;103:58–63. doi: 10.1016/j.jsat.2019.05.001
   PubMed Web of Science ®Google Scholar
• Oliva EM, Bowe T, Manhapra A, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020 Mar 07;368:m283.
   PubMedGoogle Scholar
• Larochelle MR, Lodi S, Yan S, et al. Comparative effectiveness of Opioid tapering or abrupt discontinuation vs no dosage change for Opioid overdose or suicide for patients receiving stable long-term Opioid therapy. JAMA Netw Open. 2022;5(8):e2226523. doi: 10.1001/jamanetworkopen.2022.26523
   PubMed Web of Science ®Google Scholar
• James JR, Scott JM, Klein JW, et al. Mortality after discontinuation of primary care–based chronic opioid therapy for pain: a retrospective cohort study. J Gen Intern Med. 2019;34(12):2749–2755. doi: 10.1007/s11606-019-05301-2
   PubMed Web of Science ®Google Scholar
• Henry SG, Fang S-Y, Crawford AJ, et al. Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: a population-based, statewide cohort study. J Gen Intern Med. 2023; [cited 2023 Dec 6]. doi:10.1007/s11606-023-08419-6
   Web of Science ®Google Scholar
• Metz VE, Ray GT, Palzes V, et al. Prescription opioid dose reductions and potential adverse events: a multi-site observational cohort study in diverse US health systems. J Gen Intern Med. 2023;[cited 2023 Dec 6]. doi:10.1007/s11606-023-08459-y
   PubMed Web of Science ®Google Scholar
• Binswanger IA, Shetterly SM, Xu S, et al. Opioid dose trajectories and associations with mortality, opioid use disorder, continued opioid therapy, and health plan disenrollment. JAMA Netw Open. 2022;5(10):e2234671. doi: 10.1001/jamanetworkopen.2022.34671
   PubMed Web of Science ®Google Scholar
• DiPrete BL, Ranapurwala SI, Maierhofer CN, et al. Association of opioid dose reduction with opioid overdose and opioid use disorder among patients receiving high-dose, long-term opioid therapy in North Carolina. JAMA Netw Open. 2022;5(4):e229191. doi: 10.1001/jamanetworkopen.2022.9191
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering [Internet]. 2019. Available from: https://www.fda.gov/Drugs/DrugSafety/ucm635038.htm
   Google Scholar
• HHS Guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics [Internet]. (WA) DC: US Department of Health and Human Services; 2019. Available from: https://www.hhs.gov/opioids/sites/default/files/2019-10/Dosage_Reduction_Discontinuation.pdf
   Google Scholar
• Larochelle M, Lagisetty PA, Bohnert ASB. Opioid tapering practices—time for reconsideration? JAMA. 2021;326(5):388–389. doi: 10.1001/jama.2021.11118
   PubMed Web of Science ®Google Scholar
• Perez HR, Buonora M, Cunningham CO, et al. Opioid Taper is associated with subsequent termination of care: a retrospective cohort study. J Gen Intern Med. 2019 Aug 21;35(1):36–42. doi: 10.1007/s11606-019-05227-9
   PubMed Web of Science ®Google Scholar
• Overdose death rates involving opioids, by type, United States, 1999-2019 | drug overdose | CDC Injury Center [Internet]. 2021 [cited 2022 Jan 23]. Available from: https://www.cdc.gov/drugoverdose/data/OD-deaths-2019.html
   Google Scholar